Why BGPT?
logo

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review paper



    Explore by Goal












     Quick Explanation


    CK1α is a “dual-gating” rheostat for cGAS–STING
    • Initiation: CK1α kinase activity supports cGAS abundance by limiting CRL3-dependent proteasomal degradation.
    • Termination: CK1α depletion enhances STING–TBK1–IRF3 signaling and delays STING degradation, consistent with CK1α promoting p62-dependent clearance/termination downstream of STING agonists.
    • Therapeutic concept: CK1α molecular-glue degraders suppress chronic cGAS–STING inflammation in CIN TNBC cells and potentiate STING-agonist killing in AML models.



     Long Explanation


    Paper Review (skeptical, evidence-based): “The Kinase CK1α coordinates Initiation and Termination of the cGAS–STING Pathway”
    Preprint DOI: 10.1101/2025.08.13.670063
    Visual “evidence map” (what the paper claims vs what was measured)
    • Proximity proteomics: CK1α proximity interactors were mapped with an APEX2 proximity-labeling strategy.
    • Functional DNA-sensing assays: CK1α deletion reduces IFNB1/ISGs after DNA (cGAS-dependent) stimuli; rescue requires CK1α kinase activity.
    • Protein turnover mechanism: CK1α loss reduces cGAS protein abundance without altering cGAS mRNA, and proteasome/neddylation perturbations support a CRL-linked degradation model.
    • Downstream termination model: CK1α loss increases STING–TBK1–IRF3 phosphorylation and elevates IFNB1/ISGs after STING agonists, with delayed STING degradation and altered p62 abundance.
    • Cancer relevance: CK1α molecular-glue degraders suppress chronic cGAS–STING activity in CIN TNBC cells and synergize with STING agonists to enhance apoptosis in AML models.
    Results visualization (measured dataset scale from the paper)
    Counts come directly from the manuscript text: 4,209 detected proteins in CK1α proximity labeling and 3,718 significant interactors (log2 ratio threshold and q-value), plus 1,287 proteins in CK1α-IP and ~71% overlap between IP and proximity datasets.
    Mechanistic synthesis: how CK1α could “gate” both initiation and termination
    Initiation (DNA → cGAS → STING activation)
    • Claim: CK1α kinase activity helps maintain cGAS protein levels by preventing proteasomal degradation mediated by a CRL3 E3 ubiquitin ligase architecture.
    • Key inference: If cGAS abundance is limiting, DNA sensing and downstream STING phosphorylation should drop; the manuscript reports that cGAMP production (measured by ELISA) and STING/IRF3 phosphorylation downstream of DNA stimulation are reduced in CK1α-depleted cells.
    Background anchor: cGAS produces 2′3′-cGAMP upon cytosolic DNA detection and STING activation triggers TBK1/IKKε→IRF3 phosphorylation and interferon transcription.
    Termination (STING agonist → TBK1/IRF3 activation → STING degradation clearance)
    • Claim: CK1α promotes STING pathway shutdown by facilitating STING degradation and tempering IRF3 signaling after STING agonists.
    • Proposed mediator: p62 (SQSTM1) abundance is reduced upon CK1α loss, and p62 is linked to autophagy-dependent STING clearance/termination.
    Pathway logic diagram (qualitative network)
    The diagram is a logic-style representation of the manuscript’s dual-gating claims: CK1α supports cGAS stability (reducing CRL3-driven cGAS turnover) while CK1α promotes STING degradation/termination through p62-linked clearance.
    Skeptical critique: what is strong, what is inferred, what is uncertain
    Strengths
    • Bidirectional perturbation with catalytic specificity: CK1α knockout reduces DNA-induced signaling, and rescue depends on CK1α kinase activity (kinase-dead mutants fail to restore).
    • Mechanism-linked readouts: cGAS protein changes are paired with mRNA constancy, proteasome/neddylation perturbations, and cullin dependence evidence.
    • Separation of cGAS vs STING steps: The paper uses cGAS bypass via STING agonists to show CK1α can exert opposite effects on downstream termination (enhancing STING pathway output when CK1α is depleted).
    Uncertainties / blind spots
    • CRL3 substrate receptor not fully identified: The manuscript supports CUL3 involvement and CRL-linked degradation, but the exact CRL3 substrate receptor that targets cGAS (and the CK1α→substrate-receptor mechanistic link) is not fully resolved in the provided text.
    • Proximity ≠ direct interaction: APEX2 proximity labeling and interactome/proximitome overlap suggest association patterns but do not by themselves prove direct binding or CK1α substrate phosphorylation targets.
    • Cell-model generality: Many key functional demonstrations are performed in human immortalized cell lines; while they include multiple AML lines and a TNBC line, translation to in vivo tumor microenvironments and primary immune contexts remains unproven.
    • Chemical degrader specificity/off-targets: Molecular glue degraders can have pleiotropic phenotypes through degradation beyond CK1α depending on off-target recruitments and downstream stress pathways. The manuscript uses multiple degrader molecules as partial mitigation, but direct off-target mapping is not shown in the provided text.
    What would most strongly disprove the “dual-gating” model?
    • Directly identifying the responsible CRL3 substrate receptor and showing CK1α action is mechanistically upstream of cGAS ubiquitination/turnover rather than a parallel indirect effect.
    • Demonstrating that restoring p62 levels (or blocking p62-dependent clearance) reverses CK1α-dependent termination effects on STING degradation kinetics and IRF3 activation after STING agonists.
    Research-data provenance (for reproducibility)
    The authors report that proteomics raw/extracted data were deposited in ProteomeXchange/PRIDE with dataset identifiers PXD066072 (whole proteome) and PXD066276 (CK1α IP/proteomics). They also mention an accompanying Shiny codebase for proteomics visualization/analysis hosted on GitHub: MarjorieLeduc/Shiny_PROTEOM_IC.
    Proteomics pipelines mentioned include DIA-NN and Perseus for analysis/quantification. DIA-NN is described as using neural networks and interference correction for deep proteome coverage. Perseus is cited as a platform for proteomics data analysis.


    Feedback:    

    Updated: April 07, 2026

     BGPT Paper Review


    Study Novelty

    70%

    CK1α being a “dual-gating” rheostat for initiation (cGAS stability via CRL3-linked proteolysis) and termination (STING degradation via p62-linked clearance) is a specific mechanistic consolidation of known pathway logic into a new upstream coordinator; the dual effect framing is novel, though parts of CK1α and p62/cGAS–STING regulation exist in prior literature.


    Scientific Quality

    80%

    High-quality multi-modal evidence (APEX2 proximity labeling, proteomics IP/proximity overlap, mechanistic inhibition/rescue logic with kinase-dead mutants, and pathway-step bypass using STING agonists). Main limitations are common for mechanistic cell-line work: incomplete identification of the exact CRL3 substrate receptor and limited in vivo immune-tumor context in the provided excerpt, plus residual chemical degrader off-target risk.


    Study Generality

    60%

    Mechanistic insight is strong but demonstrated primarily in selected human cell lines (THP-1, BT-549, multiple AML lines). Generality across tissues, primary immune cells, and broader tumor genetic contexts needs additional validation.


    Study Usefulness

    80%

    Actionable biological understanding of CK1α as a tunable control point for both cGAS initiation and STING termination, plus a testable translational concept using CK1α molecular-glue degraders with STING agonists. Practical impact depends on in vivo confirmation and target specificity (CRL3 substrate receptor, p62 causality).


    Study Reproducibility

    70%

    Proteomics methods and key analysis tools are specified, with PRIDE dataset identifiers and a code repository mentioned. Remaining reproducibility constraints include missing full numerical details in the excerpt and lack (in the provided text) of comprehensive off-target characterization for degraders.


    Explanatory Depth

    80%

    Mechanistic depth is substantial: catalytic requirement, protein stability vs mRNA separation, CRL-linked turnover logic, and termination timing/clearance with p62 implicated. However, direct phosphorylation targets and the identity of the CRL3 substrate receptor are not fully resolved in the provided text.


    🎁 Authors: Collect 301 Free Science Tokens (≈ $30.1 USD)

    Claim My Author Tokens

    Use for 75 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $30.1 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    It parses the PRIDE proteomics datasets (PXD066072, PXD066276) to reproduce CK1α proximitome/interactome overlaps and generates differential-abundance QC and enrichment plots from the reported thresholds.



     Hypothesis Graveyard


    A “pure transcriptional” model (CK1α alters interferon gene expression broadly) is less likely because the paper reports cGAS mRNA is unchanged while cGAS protein drops, and kinase-dead CK1α fails to rescue cGAS–STING DNA signaling.


    A “CK1α has no termination role” model is less likely because CK1α depletion increases TBK1/IRF3/STING phosphorylation and delays STING degradation upon STING agonist stimulation.

     Science Art


    Paper Review: The Kinase CK1α coordinates Initiation and Termination of the cGAS-STING Pathway Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending